
Changes announced to Hpat system for studying medicine
have announced changes to the entry requirements for studying medicine following concerns that some students may have found a way to practise for aptitude tests known as the Hpat, or Health Professions Admission Test.
Under the admissions process for medical schools, applicants are required to combine their Leaving Certificate results with those from the Hpat which was introduced in 2009 to assess skills deemed important for medicine. Those the Hpat assesses include reasoning, problem-solving and interpersonal skills.
While the 2½-hour test was initially envisaged as one which candidates could not study for, there is now an extensive private tuition industry where students can spend up to €800 over 15 weeks to prepare for the assessment.
[
Colleges to alter entry requirements for medicine amid concern applicants 'gaming' aptitude test
Opens in new window
]
The Hpat is marked out of a total of 300 points, which is added to a candidate's Leaving Cert score. For example, a student who gets 500 points in the Leaving Cert and 200 points in the Hpat gets a combined score of 700 points.
About 3,000 students take the test each year, which is required to study undergraduate medicine at the University of Galway, the Royal College of Surgeons in Ireland, Trinity College Dublin, UCC and UCD. University of Limerick also requires the Hpat for entry to its master's degree in occupational therapy and speech and language therapy.
Under the revised plans, the maximum points the Hpat can deliver is to be reduced to 150 points.
The changes are being announced now for the 2027 intake to allow potential applicants to make choices in advance of their two-year Leaving Certificate cycle. The changes will not affect those sitting their Leaving Certificates in 2025 or 2026.
The Hpat was introduced under then minister for education
Mary Hanafin
, following concern that only those scoring very high Leaving Cert points were guaranteed entry to medicine. She said at the time that students would no longer need a 'perfect Leaving Cert' to enter medicine.
However, concern grew that students who are able to afford extra support for their exams and Hpat tests are at a significant advantage when it comes to studying medicine.
Latest
Higher Education Authority
data, for example, show about 33 per cent of medicine students are from affluent backgrounds, compared with 18 per cent of students overall. Only 3 per cent of medicine students are from disadvantaged backgrounds, compared to 11 per cent overall.
Announcing the modifications on Friday, the
Irish Universities Association
said the primary requirement to present both the Leaving Certificate result and Hpat result for the calculation of points for medicine will not change.
[
CAO 2025: A guide to some lesser-known courses
Opens in new window
]
'However, the way in which both Leaving Cert and Hpat points are counted will change. Leaving Certificate points above 550 will no longer be moderated, and the maximum possible Hpat points will be reduced from 300 to 150.'
From 2027, the maximum combined Leaving Certificate and Hpat points for Medicine will be 775, being 625 from the Leaving Certificate and 150 from the Hpat.
This will differ from the current maximum of 865 points made up of 565 points from the Leaving Certificate and 300 from the Hpat.
The existing rule that the Hpat must be taken in the year of
Cental Applications Office
application will continue. Applicants will continue to need to meet the minimum entry requirements as well as the existing 480 points minimum requirement, all in the same sitting of the Leaving Certificate.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

The Journal
a day ago
- The Journal
Synthetic cannabinoid HHC has now been classified as an illegal drug
THE SEMI-SYNTHETIC CANNABINOID product HHC has been banned in Ireland. Health Minister Jennifer Carroll MacNeill announced today that Hexahydrocannabinol (HHC) has been classed as a Schedule 1 controlled drug under the Misuse of Drugs Act 1977. This means that the import, export, production, possession, sale, and supply of products containing HHC is now illegal. HHC produces similar effects to THC, which is a natural cannabinoid found in the cannabis plant. However, HHC is a chemically modified substance. It has been available in Ireland in vapes and edibles but until today was not subject to legal restrictions as it had not yet classified as a controlled substance. The College of Psychiatrists has previously called on the government to add HHC and any semi-synthetic cannabinoid to the list of prohibited substances for manufacture, distribution and sale. In September of last year, Consultant Specialist Addiction Psychiatrist Professor Colin O'Gara said that although it is initially seen to be a 'harmless' drug, it 'can have devastating effects on a young person's mental health; we have treated young men suffering from severe psychosis as a result of vaping HHC'. Advertisement Since HHC was first detected in Ireland in 2022, it has been linked with episodes of psychosis and hospitalisation. A recent study by researchers in University Hospital Galway found that HHC was the second most common drug used by patients presenting with psychosis over a 21-month period. HHC is one of 14 new substances that have been newly classified as controlled drugs, alongside synthetic opioids and semi-synthetic cannaboids. The drugs were identified by the EU and by the UN Commission for Narcotic Drugs as posing a serious risk to public health. The substances being classified as illegal gives gardaí added powers of enforcement in combatting the trade in illegal drugs. The addition of these substances to the Schedules of the Misuse of Drugs Acts gives added powers of enforcement to An Garda Siochana combatting the trade in illicit drugs. Carroll MacNeill said the sale of HHC as vapes in 'attractive packaging', or in edible jelly form is a 'marketing ploy' aimed at young people. Junior Minister for the National Drug Strategy Jennifer Murnane O'Connor added that HHC is responsible for hospitalisations and psychotic episodes and that there are many people struggling with addition as a result of HHC and similar drugs. She urged those seeking help for themselves or a loved one to contact the HSE Drugs and Alcohol Helpline. The HSE operates a confidential freephone Drug and Alcohol Helpline: 1800 459 459 from Monday to Friday between 9:30 am and 5:30 pm or through email at helpline@ Readers like you are keeping these stories free for everyone... A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation. Learn More Support The Journal


RTÉ News
a day ago
- RTÉ News
HHC drug to be banned in Ireland, Government says
Hexahydrocannabinol (HHC) has been classified as an illegal drug by the Government. This means that the import, export, production, possession, sale and supply of products containing the man-made substance is now illegal. In a statement, the Government said: "The semi-synthetic cannabinoid has similar effects to cannabis and has been commonly sold as e-cigarettes or vape pens, in herbal mixtures, oils, edible jellies and cakes and as tinctures. "Since it was first detected in Ireland in 2022, it has been linked with episodes of psychosis and hospitalisation. "A recent study by researchers in University Hospital Galway found that HHC was the second most common drug used by patients presenting with psychosis over a 21-month period."


RTÉ News
a day ago
- RTÉ News
Nearly 25% of doctors work over 48 hours a week
Almost a quarter of doctors have said they are working more than 48 hours a week, according to a Medical Council report. The Medical Workforce Intelligence Report 2024 found doctors working in surgery, obstetrics and gynaecology were most likely to work over 48 hours a week. Around 45% of those who self-reported to work over 48 hours said they were working in direct patient care. The report also said around one quarter, 26.1%, of doctors reported experiencing difficulty providing a patient with sufficient care at least once a week or more, while over one-third, 33.6%, reported never experiencing difficulty. Almost three-quarters, 73.0%, said "pressure on workloads" was the greatest barrier to providing a patient with sufficient care at least once a week or more. The report found there were 20,962 clinically active doctors working in the State in 2024 and said 78.8% of doctors retained their place on the Medical Council Register last year. It said the mean age of doctors was 43.7 years old and over 20% were 55 and older. Over 11,000 of doctors in the State were male (52.8%) and over 9,900 were female (47.2%). Almost half of doctors worked in either general practice (25.9%) and medicine (23.4%). The third largest discipline was surgery, which the report said represented 11.9% of clinically active doctors. Almost 8,990 doctors were based in Dublin, representing 42.9% of the total number, and just 34 doctors in Leitrim, representing 0.2% of the total number. The report found that 27.8% of doctors in the State have an "international basic medical qualification" from outside Ireland, the EU and the UK. This is up from 25.7% in 2023 and 23.3% in 2022. It said almost 40% of doctors with an international qualification received it from Pakistan and 21.3% have a qualification from Sudan. Commenting on the report, CEO of the Medical Council Dr Maria O'Kane said it has seen a "phenomenal increase" in the number of doctors joining the Medical Council Register in recent years. However, she added: "Despite there being over 30,000 doctors on the register at the end of 2024, our research today shows that only 20,692 doctors report being clinically active in Ireland in the same year." Dr O'Kane said last month's report on General Practice in Ireland"aligns strongly" with the Medical Council's data and it "shares the same views on the urgent need for strategic, sustainable investment in training, recruitment, and retention – for GPs and other doctors alike".